Actively Recruiting
Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD
Led by Brigham and Women's Hospital · Updated on 2024-07-03
20
Participants Needed
1
Research Sites
54 weeks
Total Duration
On this page
Sponsors
B
Brigham and Women's Hospital
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.
CONDITIONS
Official Title
Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English-speaking adults aged 18 and above
- Any DSM-5 substance use disorder
- Can identify at least 2 individuals who can act as points of contact following discharge from the hospital
You will not qualify if you...
- Psychotic disorder, active suicidality, or homicidality
- Condition likely to be terminal during the study period
- Unable to perform consent due to impaired mental status
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
J
Joji Suzuki, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here